Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pharming Technologies B.V.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Aged at least 18 years
Signed informed consent
Comfirmed diagnosis of HAE with baseline plasma level of functional C1INH activity of less than 50% of normal, and/or proven HAE ,mutation in C1INH gene.
You may not be if
A history of anaphylaxis or severe allergy (i.e. requiring medication) to food, proteins and/or drugs.
A history of allergic reactions to C1INH products or rabbit protein.
Any reported SAE related to study drug administration (withdrawal criterium)
Elevated IgE against rabbit dander (\>0.35 kU/L; ImmunoCap assay; Phadia)
A diagnosis of acquired C1INH deficiency.
Woman of child bearing potential, pregnancy or breast-feeding
previous treatment within the last 3 months with plasma-derived C1INH
Any clinically significant abnormality in the routine haematology, biochemistry and urinalysis
Any condition or treatment that in the opinion of the investigator might interfere with the evaluation of the study objectives.